Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 5/20 | 0.67 |
| ▸ | SLC10A1 | Q14973 | 1/20 | 0.63 |
| ▸ | GPBAR1 | Q8TDU6 | 4/20 | 0.61 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.61 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.58 |
| ▸ | CES2 | O00748 | 1/20 | 0.48 |
| ▸ | TOP2A | P11388 | 1/20 | 0.48 |
| ▸ | CES1 | P23141 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28453559 | 1.00 | PTPN1 (0.67) | PTPN1SLC10A1GPBAR1PRKCDNR1H4 | |
| SCHEMBL476921 | 0.81 | SLC10A1 (0.73) | PTPN1SLC10A1GPBAR1PRKCDNR1H4 | |
| SCHEMBL13384623 | 0.81 | SLC10A1 (0.73) | PTPN1SLC10A1GPBAR1PRKCDNR1H4 | |
| SCHEMBL476920 | 0.81 | SLC10A1 (0.73) | PTPN1SLC10A1GPBAR1PRKCDNR1H4 | |
| SCHEMBL13403268 | 0.81 | SLC10A1 (0.73) | PTPN1SLC10A1GPBAR1PRKCDNR1H4 | |
| SCHEMBL8068676 | 0.80 | PTPN1 (1.00) | PTPN1SLC10A1GPBAR1PRKCDNR1H4 | |
| SCHEMBL160601 | 0.80 | PTPN1 (1.00) | PTPN1SLC10A1GPBAR1PRKCDNR1H4 | |
| SCHEMBL17867237 | 0.79 | SLC10A1 (0.55) | PTPN1SLC10A1GPBAR1PRKCDNR1H4 | |
| SCHEMBL17388705 | 0.79 | PTPN1 (0.57) | PTPN1GPBAR1 | |
| SCHEMBL10061553 | 0.78 | NR1H4 (0.74) | PTPN1SLC10A1GPBAR1PRKCDNR1H4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4724593-A2 | POLYPEPTIDES FOR PREPARING TERPENOID COMPOUNDS | Firmenich SA (CH) | 2026-04-15 | — | — | EP | disclosed |
| EP-4724592-A2 | PREPARATION OF TERPENOID COMPOUNDS | Firmenich SA (CH) | 2026-04-15 | — | — | EP | disclosed |
| US-20260043058-A1 | SHC ENZYMES AND ENZYME VARIANTS | GIVAUDAN SA (CH) | 2026-02-12 | — | — | US | disclosed |
| US-20250361536-A1 | SQUALENE HOPENE CYCLASE (SHC) VARIANTS | GIVAUDAN SA (CH) | 2025-11-27 | — | — | US | disclosed |
| US-12416027-B2 | Squalene hopene cyclase (SHC) variants | GIVAUDAN SA (CH) | 2025-09-16 | — | — | US | disclosed |
| EP-4608876-A2 | ENDOCYTIC AGENTS | BioVentures, LLC (US) | 2025-09-03 | — | — | EP | disclosed |
| US-12344531-B2 | Silica with ultra-fast dissolution properties | SIL'INNOV SRCL (BE) | 2025-07-01 | — | — | US | disclosed |
| EP-4493685-A1 | SHC ENZYMES AND ENZYME VARIANTS | Givaudan SA (CH) | 2025-01-22 | — | — | EP | disclosed |
| WO-2024256472-A2 | PREPARATION OF TERPENOID COMPOUNDS | FIRMENICH SA (CH) | 2024-12-19 | — | — | WO | disclosed |
| US-20240368647-A1 | ENZYMES AND APPLICATIONS THEREOF | PROTEUS SA (FR) | 2024-11-07 | — | — | US | disclosed |
| CN-116615555-A | Enzymatic monocyclization of acyclic monoterpenes | 斯图加特大学 | 2023-08-18 | — | — | CN | disclosed |
| US-20230220431-A1 | ENZYMES AND APPLICATIONS THEREOF | GIVAUDAN SA (CH) | 2023-07-13 | — | — | US | disclosed |
| US-20230021613-A1 | SQUALENE HOPENE CYCLASE (SHC) VARIANTS | GIVAUDAN SA (CH) | 2023-01-26 | — | — | US | disclosed |
| EP-4069836-A1 | SQUALENE HOPENE CYCLASE (SHC) VARIANTS | Givaudan SA (CH) | 2022-10-12 | — | — | EP | disclosed |
| US-11466299-B2 | Enzymes and applications thereof | GIVAUDAN S.A. (CH) | 2022-10-11 | — | — | US | disclosed |
| CN-115052982-A | Squalene agamene cyclase (SHC) variants | 奇华顿股份有限公司 | 2022-09-13 | — | — | CN | disclosed |
| US-11427476-B2 | Mesoporous silicas and method for the synthesis thereof | Sil'innov S.c.r.l. (BE) | 2022-08-30 | — | — | US | disclosed |
| WO-2022106522-A1 | ENZYMATIC MONOCYCLIZATION OF ACYCLIC MONOTERPENOIDS | Universität Stuttgart (DE) | 2022-05-27 | — | — | WO | disclosed |
| US-20220127650-A1 | Process | GIVAUDAN SA (CH) | 2022-04-28 | — | — | US | disclosed |
| US-11261450-B2 | Recombinant cell, method for producing recombinant cell, and method for producing isoprene or terpene | SEKISUI CHEMICAL CO., LTD. (JP) | 2022-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240368647-A1 | ENZYMES AND APPLICATIONS THEREOF | HAO1, HLCS, HACL2 | PTPN1 1674/4885SLC10A1 2726/4885GPBAR1 3868/4885 |
| US-20260043058-A1 | SHC ENZYMES AND ENZYME VARIANTS | SQLE, DHCR7, CYP51A1 | PTPN1 1232/4885SLC10A1 3875/4885GPBAR1 930/4885 |
| US-20230220431-A1 | ENZYMES AND APPLICATIONS THEREOF | HAO1, HLCS, HACL2 | PTPN1 1674/4885SLC10A1 2726/4885GPBAR1 3868/4885 |
| US-11466299-B2 | Enzymes and applications thereof | HAO1, HLCS, HACL2 | PTPN1 1674/4885SLC10A1 2726/4885GPBAR1 3868/4885 |
| US-12344531-B2 | Silica with ultra-fast dissolution properties | SI, TREH, DDOST | PTPN1 3729/4885SLC10A1 1408/4885GPBAR1 3770/4885 |
| US-11427476-B2 | Mesoporous silicas and method for the synthesis thereof | LSS, SGMS2, SGMS1 | PTPN1 3457/4885SLC10A1 2047/4885GPBAR1 3007/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.